SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 10,061.60 |
Enterprise Value ($M) | 11,008.46 |
Book Value ($M) | 3,529.99 |
Book Value / Share | 15.88 |
Price / Book | 2.85 |
NCAV ($M) | -286.13 |
NCAV / Share | -1.29 |
Price / NCAV | -35.16 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.02 |
Return on Assets (ROA) | 0.02 |
Return on Equity (ROE) | 0.02 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.89 |
Current Ratio | 2.17 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2,454.07 |
Assets | 6,270.20 |
Liabilities | 2,740.20 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Wellington Management Group Llp | 9.49 | 404.21 | |
13G | BlackRock, Inc. | 10.20 | 2.53 | |
13G/A | Massachusetts Financial Services Co /ma/ | 10.50 | -0.26 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
99,461 | 882,232 | 11.27 | |
104,183 | 981,475 | 10.61 | |
76,642 | 536,731 | 14.28 | |
119,770 | 1,209,901 | 9.90 | |
(click for more detail) |
Similar Companies | |
---|---|
PBH – Prestige Consumer Healthcare Inc. | PFE – Pfizer Inc. |
PRGO – Perrigo Company plc | RCUS – Arcus Biosciences, Inc. |
RFL – Rafael Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io